Search research articles
Contact Us
Filters
Showing results (91-100 of 96) with videos related to
Page
of 10
Sort By:
You have reached the last page of results.
This site can display upto 96 results.
Cancer Chemotherapy and Pharmacology
|
January 1, 1995
Pharmacokinetic evaluation of two different formulations of megestrol acetate in patients with advanced malignancies
C M Camaggi, E Strocchi, A Martoni, et al.
Tumori
|
August 31, 1994
Dose intensification of chemotherapy in advanced breast cancer: a feasibility phase II study
P Pedrazzoli, C Zamagni, A Martoni, et al.
Tumori
|
July 1, 1996
A new regimen of cisplatin, epirubicin and methotrexate (PEM-3) as primary chemotherapy for locally advanced bladder cancer
N Cacciari, A Martoni, A P Rossi, et al.
Lung Cancer (Amsterdam, Netherlands)
|
December 30, 1998
Multicenter randomized clinical trial on high-dose epirubicin plus cis-platinum versus vinorelbine plus cis-platinum in advanced non small cell lung cancer
A Martoni, M Guaraldi, E Piana, et al.
Gynecologic Oncology
|
June 1, 1997
Intraperitoneal carboplatin with or without interferon-alpha in advanced ovarian cancer patients with minimal residual disease at second look: a prospective randomized trial of 111 patients. G.O.N.O. Gruppo Oncologic Nord Ovest
M Bruzzone, A Rubagotti, A Gadducci, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 20, 1999
Prospective randomized trial of docetaxel versus mitomycin plus vinblastine in patients with metastatic breast cancer progressing despite previous anthracycline-containing chemotherapy. 304 Study Group
J M Nabholtz, H J Senn, W R Bezwoda, et al.
Page
of 10
Search research articles
Search
Showing results (91-100 of 96) with videos related to
Sort By:
Page
of 10
You have reached the last page of results.
This site can display upto 96 results.
Cancer Chemotherapy and Pharmacology
|
January 1, 1995
Pharmacokinetic evaluation of two different formulations of megestrol acetate in patients with advanced malignancies
C M Camaggi, E Strocchi, A Martoni, et al.
Tumori
|
August 31, 1994
Dose intensification of chemotherapy in advanced breast cancer: a feasibility phase II study
P Pedrazzoli, C Zamagni, A Martoni, et al.
Tumori
|
July 1, 1996
A new regimen of cisplatin, epirubicin and methotrexate (PEM-3) as primary chemotherapy for locally advanced bladder cancer
N Cacciari, A Martoni, A P Rossi, et al.
Lung Cancer (Amsterdam, Netherlands)
|
December 30, 1998
Multicenter randomized clinical trial on high-dose epirubicin plus cis-platinum versus vinorelbine plus cis-platinum in advanced non small cell lung cancer
A Martoni, M Guaraldi, E Piana, et al.
Gynecologic Oncology
|
June 1, 1997
Intraperitoneal carboplatin with or without interferon-alpha in advanced ovarian cancer patients with minimal residual disease at second look: a prospective randomized trial of 111 patients. G.O.N.O. Gruppo Oncologic Nord Ovest
M Bruzzone, A Rubagotti, A Gadducci, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 20, 1999
Prospective randomized trial of docetaxel versus mitomycin plus vinblastine in patients with metastatic breast cancer progressing despite previous anthracycline-containing chemotherapy. 304 Study Group
J M Nabholtz, H J Senn, W R Bezwoda, et al.
Page
of 10